Staurosporine induces different cell death forms in cultured rat astrocytes

Radiology and Oncology

Volumn 46, Issue 4, 2012, Pages 312-320

  Simenc, Janez ^a,b   Lipnik Stangelj, Metoda ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Apoptosis; Astrocytes; Flow cytometry; Necroptosis; Reactive oxygen species; Staurosporine

Indexed keywords

BUTYLATED HYDROXYANISOLE; CASPASE; REACTIVE OXYGEN METABOLITE; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL REGENERATION; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; NECROPTOSIS; NEWBORN; NONHUMAN; RAT;

EID: 84877945345     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0036-9     Document Type: Article

References (28)

1. Jiang YG, Peng Y, Koussougbo KS. Necroptosis: a novel therapeutic target for glioblastoma. Med Hypotheses 2011; 76: 350-2.
2. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Cell Mol Biol 2008; 9: 231-41. (Pubitemid 351301823)
3. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2009; 16: 3-11.
4. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43. (Pubitemid 44911892)
5. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 2: 112-9.
6. Holle, N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 6: 489-95.
7. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation driven assembly of the RIP1 RIP3 complex regulates programmed necrosis and virus induced inflammation. Cell 2009; 137: 1112-23.
8. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332-6.
9. Rollins S, Perkins E, Mandybur G, Zhang JH. Oxyhemoglobin produces necrosis, not apoptosis in astrocytes. Brain Res 2002; 945: 41-9. (Pubitemid 34756575)
10. Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol 2004; 72: 111-27. (Pubitemid 38519589)
11. Laird MD, Wakade C, Alleyne CH, Dhandapani KM. Hemin induced necroptosis involves glutation depetion in mouse astrocytes. Free Radic Biol Med 2008; 45: 1103-14.
12. Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 2004; 1: 181-93. (Pubitemid 38030221)
13. Šimenc J, Lipnik-Štangelj M. Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes. Drug Chem Toxicol 2012; 35: 399-405.
14. Eruslanov E. Kusmartsev S. Identification of ROS using oxidized DCFDA and flow cytometry. In: Armstrong D, editor. Advanced protocols in oxidative stress II, Methods in Molecular Biology. New York: Humana Press; 2010. p. 57-72.
15. Martin SJ, Reutelingsperger CEM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-56.
16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
17. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994; 170: 145-57. (Pubitemid 24122504)
18. Todorovic V, Sersa G, Mlakar V, Glavac D, Cemazar M. Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin. Radiol Oncol 2012; 46: 32-45.
19. Vranic A. New developments in surgery of malignant gliomas. Radiol Oncol 2011; 45: 159-65.
20. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, et al. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 2001; 20: 1193-202. (Pubitemid 32226245)
21. Belmokhtar CA, Hillion J, Ségal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 2001; 20: 3354-62. (Pubitemid 32588984)
22. Xue LY, Chiu SM, Oleinick NL. Staurosporine-induced death of MCF-7 human breast cancer cells: a distinction between caspase-3 dependent steps of apoptosis and the critical lethal lesions. Exp Cell Res 2003; 283: 135-45. (Pubitemid 36269020)
23. Zhang XD, Gillespie SK, Hersey P. Staurosporine induces apoptosis of melanoma by both caspase dependent and independent apoptotic pathways. Mol Cancer Ther 2004; 3: 187-97. (Pubitemid 39193693)
24. D'Alimonte I, Ballerini P, Nargi E, Buccella S, Giuliani P, Di Iorio P, et al. Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation. Neurosci Lett 2007; 418: 66-71. (Pubitemid 46602691)
25. Kim SY, Morgan MJ, Choksi S, Liu ZG. TNF induced activation of the Nox 1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007; 26: 675-87. (Pubitemid 46856240)
26. Song JH, Bellail A, Tse MCL, Wee Yong V, Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis inducing ligand induced apoptosis. J Neurosci 2006; 26: 3299-308.
27. Sharon Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in Response to extensive DNA damage via TNF-a feedforward signaling. Cell 2011; 145: 92-103.
28. Mao H, Lebrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest 2012, 30: 48-56.